Back to mobile site

More on INO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+60.7% Growth)
- Ratings (5.6 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INO Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 23.25M
Short-term investments - certificates of deposit 96.44M
Accounts receivable 17.46M
Accounts receivable from affiliated entity
Prepaid expenses and other current assets 1.39M
Prepaid expenses and other current assets from affiliated entity 1.7M
Total current assets 140.23M
Fixed assets, net 8.99M
Intangible assets, net 8.04M
Goodwill 10.51M
Investment in affiliated entity 20.76M
Other assets 1.48M
Total assets 194.55M
Accounts payable and accrued expenses 16.18M
Accounts payable and accrued expenses due to affiliated entity 493.42K
Accrued clinical trial expenses 7.22M
Common stock warrants 1.81M
Deferred revenue 14.83M
Deferred revenue from affiliated entity 438.54K
Total current liabilities 41.37M
Deferred revenue, net of current portion 365.69K
Deferred revenue from affiliated entity, net of current portion 180.44K
Deferred rent, net of current portion 5.47M
Deferred tax liabilities 175.64K
Total liabilities 47.57M
Common stock 73.97K
Additional paid-in capital 552.75M
Accumulated deficit -408.6M
Accumulated other comprehensive income 2.66M
Total Inovio Pharmaceuticals, Inc. stockholders' equity 146.88M
Non-controlling interest 96.27K
Total stockholders' equity 146.98M
Total liabilities and stockholders' equity 194.55M